Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Vivo Bio Tech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹13.98up ₹0.11 (0.79%)BSE ₹13.95
Share price at the NSE close on 29 Oct 2026. Previous close ₹13.87.
29 Oct: open ₹13.58, high ₹14.09, low ₹13.49
52-week range of BSE trades to 29 Oct 2026
₹12.20Low, 26 Oct 2026₹35.76High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹31 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,84371.4% delivered
Vivo Bio Tech board meetings
135 filed, newest first. Page 3 of 3.
Nov 2019
4 Nov · Board meeting
Meeting on 13 Nov 2019: quarterly results
Aug 2019
5 Aug · Board meeting
Meeting on 12 Aug 2019: quarterly results
May 2019
9 May · Board meeting
Meeting on 17 May 2019: audited results
Feb 2019
4 Feb · Board meeting
Meeting on 12 Feb 2019: quarterly results
Jan 2019
7 Jan · Board meeting
Meeting on 7 Jan 2019
Oct 2018
Aug 2018
May 2018
Sep 2017
Aug 2017
May 2017
Apr 2017
Dec 2016
Jul 2016
30 Jul · Board meeting
Meeting of Board of Directors of the company will be held on August 11, 2016, inter alia, to consider the Unaudited Financial Results for quarter ....
May 2016
28 May · Board meeting
Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, have approved the Vivo Bio ESOP Scheme 2016 and notice of postal Ballot.
Jan 2016
Aug 2015
31 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 31, 2015, inter alia, has transacted following business: - Approved the ....
Mar 2015
20 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 20, 2015, has considered and approved appointment of Mrs. Sharmistha Manna as ....
Sep 2014
1 Sep · Board meeting
Board of Directors of the Company at its meeting held on August 30, 2014, inter alia, has transacted the following: - Approved the Appointment ....
May 2014
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2014, inter alia, has transacted the following : 1. Considered and approved ....
Aug 2013
29 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 29, 2013, has transacted the following : 1. Approved the Notice and Directors ....
Jul 2013
30 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 30, 2013, has transacted the following business: 1. Approved the Resignation ....
May 2012
14 May · Board meeting
Board of Directors of the Company at its meeting held on May 12, 2012, inter alia, has approved the re-appointment of Dr. A. Sankaranarayanan ....
Dec 2010
24 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 24, 2010, inter alia, has transacted the following business: 1. Approved ....
Sep 2010
1 Sep · Board meeting
Board of Directors of the Company at its meeting held on August 31, 2010, inter alia, has transacted the following business: 1. The 23rd ....
Jul 2010